SCHEMBL16480404

SCHEMBL16480404

Cc1ccc(N2C(=O)CCC2C)cc1Cl

nearest known ligand 0.53

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 3/20 0.53
SLC6A4 P31645 3/20 0.53
SLC6A3 Q01959 2/20 0.53
PKM P14618 1/20 0.49
ALDH1A1 P00352 3/20 0.47
SMN1; SMN2 Q16637 3/20 0.47
HPGD P15428 1/20 0.47
L3MBTL1 Q9Y468 3/20 0.45
KMT2A Q03164 3/20 0.45
POLB P06746 1/20 0.44
MAPT P10636 2/20 0.40
GFER P55789 1/20 0.40
ABL1 P00519 2/20 0.40
MEN1 O00255 2/20 0.40
LMNA P02545 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16480426 0.88 SLC6A2 (0.53) SLC6A2SLC6A4SLC6A3PKMALDH1A1
SCHEMBL16480476 0.88 SLC6A2 (0.68) SLC6A2SLC6A4SLC6A3ALDH1A1SMN1; SMN2
SCHEMBL16480395 0.84 SLC6A2 (0.52) SLC6A2SLC6A4SLC6A3ALDH1A1HPGD
SCHEMBL9893163 0.82 CCR1 (0.45) SLC6A2SLC6A4SLC6A3ALDH1A1SMN1; SMN2
SCHEMBL9108353 0.81 KMT2A (0.51) PKMALDH1A1SMN1; SMN2HPGDL3MBTL1
SCHEMBL9891770 0.81 PKM (0.46) SLC6A2SLC6A4SLC6A3PKMALDH1A1
SCHEMBL9108362 0.81 KMT2A (0.51) PKMALDH1A1SMN1; SMN2HPGDL3MBTL1
SCHEMBL16480372 0.81 SLC6A2 (0.52) SLC6A2SLC6A4SLC6A3ABL1
SCHEMBL13934938 0.80 AR (0.62) SLC6A2SLC6A4SLC6A3
SCHEMBL22658820 0.79 SLC6A2 (0.46) SLC6A2SLC6A4SLC6A3ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2384320-B1 PYRROLIDINE COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR BOEHRINGER INGELHEIM INT (DE) 2015-03-04 EP disclosed
US-8629157-B2 Pyrrolidine compounds which modulate the CB2 receptor BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-01-14 US disclosed